Correlation Between Bristol Myers and CBOE Crude

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and CBOE Crude at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and CBOE Crude into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and CBOE Crude Oil, you can compare the effects of market volatilities on Bristol Myers and CBOE Crude and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of CBOE Crude. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and CBOE Crude.

Diversification Opportunities for Bristol Myers and CBOE Crude

-0.31

Correlation Coefficient

Bristol Myers  CBOE Crude

Very good diversification

The 3 months correlation between Bristol and CBOE is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and CBOE Crude Oil in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CBOE Crude Oil and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with CBOE Crude. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CBOE Crude Oil has no effect on the direction of Bristol Myers i.e., Bristol Myers and CBOE Crude go up and down completely randomly.

Pair Corralation between Bristol Myers and CBOE Crude

Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 0.76 times more return on investment than CBOE Crude. However, Bristol Myers Squibb is 1.32 times less risky than CBOE Crude. It trades about 0.02 of its potential returns per unit of risk. CBOE Crude Oil is currently generating about 0.01 per unit of risk. If you would invest  89,618  in Bristol Myers Squibb on September 19, 2024 and sell it today you would earn a total of  3,537  from holding Bristol Myers Squibb or generate 3.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	78.31%
Values	Daily Returns

Bristol Myers Squibb  vs.  CBOE Crude Oil

Pair Trading with Bristol Myers and CBOE Crude

The main advantage of trading using opposite Bristol Myers and CBOE Crude positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, CBOE Crude can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CBOE Crude will offset losses from the drop in CBOE Crude's long position.

The idea behind Bristol Myers Squibb and CBOE Crude Oil pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.